5.3. 2012 The European Commission is planning to adopt new regulation on the risk assessment of genetically engineered plants used in food and feed. However, the standards are not sufficiently rigorous to exclude risks to human health and the environment. Testbiotech published a tabled overview on some deficiencies on 25 of January 2012 (http://www.testbiotech.org/en/node/613). After a meeting with the Commission on 14 of February, Testbiotech continues to maintain the concerns.
The NGOs Testbiotech and Gen-ethische Netzwerk (GeN) have today published an open letter addressed to the German Chancellor, Angela Merkel, calling on her to stop the creation of new variations of the bird flu virus and back limited access to genetic data. Scientists have been able to manufacture an H5N1 type virus in the laboratory, which is extremely dangerous for mammals. The researchers agreed on 20 January 2012 to a moratorium in order to give the public an opportunity to take up a position on this issue.
Insecticidal Bt toxins such as those produced in genetically engineered plants can be detrimental to human cells. This is a result of recent research led by researchers at the University of Caen (France). Their experiments showed that toxins produced in, for example, the genetically engineered maize MON810, can significantly impact the viability of human cells. The effects were observed with relatively high concentrations of the toxins, nevertheless there is cause for concern. For the first time, experiments have now shown that they can have an toxic effect to human cells.
In a letter to Commissioner Dalli, Testbiotech and GeneWatch UK give new evidence of EFSA´s failure to perform risk assessment of genetically engineered plants. A detailed analysis of original documents as filed by Monsanto for their genetically engineered maize sold under brand of Genuity VT Triple PRO shows that crucial documents do not meet the standards of so called Good Laboratory Practice (GLP standards).